Piotr Witkowski, MD, PhD, discusses the CD40L inhibitor’s efficacy in improving outcomes for patients with T1D undergoing islet transplant.
Piotr Witkowski, MD, PhD
Advertisement
Piotr Witkowski, MD, PhD, is a professor of surgery in the Transplantation Institute at the University of Chicago.
Articles by Piotr Witkowski, MD, PhD
Witkowski discusses the data presented at ATTD 2026, highlighting the investigative anti-CD40L monoclonal antibody in facilitating insulin independence.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
Asthma Phenotypes and Endotypes: Defining the Terms
2
Diabetes Dialogue: Tech, Screening, and Care Highlights from ADCES 2026
3
Recent AAD Guidelines Address Pediatric Atopic Dermatitis Prevention
4
Insulin Icodec Now Available for Type 2 Diabetes in US
5